<?xml version="1.0"?>
<?xml-stylesheet type="text/css" href="http://www.feuxdelamour.com/v4/skins/common/feed.css?303"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="fr">
		<id>http://www.feuxdelamour.com/v4/index.php?action=history&amp;feed=atom&amp;title=A_Secret_Artillery_For_the_Sitaxentan</id>
		<title>A Secret Artillery For the Sitaxentan - Historique des versions</title>
		<link rel="self" type="application/atom+xml" href="http://www.feuxdelamour.com/v4/index.php?action=history&amp;feed=atom&amp;title=A_Secret_Artillery_For_the_Sitaxentan"/>
		<link rel="alternate" type="text/html" href="http://www.feuxdelamour.com/v4/index.php?title=A_Secret_Artillery_For_the_Sitaxentan&amp;action=history"/>
		<updated>2026-04-12T06:45:53Z</updated>
		<subtitle>Historique pour cette page sur le wiki</subtitle>
		<generator>MediaWiki 1.20alpha</generator>

	<entry>
		<id>http://www.feuxdelamour.com/v4/index.php?title=A_Secret_Artillery_For_the_Sitaxentan&amp;diff=57112&amp;oldid=prev</id>
		<title>Sextown39 : Page créée avec « In the mild/moderate SOI group, the vast majority (&gt;60%) of patients were discharged, even in the ��80-year-old group home. Conversely, in the extreme SOI group, a min... »</title>
		<link rel="alternate" type="text/html" href="http://www.feuxdelamour.com/v4/index.php?title=A_Secret_Artillery_For_the_Sitaxentan&amp;diff=57112&amp;oldid=prev"/>
				<updated>2017-01-12T11:00:58Z</updated>
		
		<summary type="html">&lt;p&gt;Page créée avec « In the mild/moderate SOI group, the vast majority (&amp;gt;60%) of patients were discharged, even in the ��80-year-old group home. Conversely, in the extreme SOI group, a min... »&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Nouvelle page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;In the mild/moderate SOI group, the vast majority (&amp;gt;60%) of patients were discharged, even in the ��80-year-old group home. Conversely, in the extreme SOI group, a minority of patients in the ��80-year-old group (&amp;gt;25%) were discharged home. Figure 2 Discharge home by Severity of comorbid illness (SOI) by age. Resource utilization Median in-hospital costs in the mild/moderate, major, and [https://en.wikipedia.org/wiki/Sitaxentan Sitaxentan] extreme SOI strata were ��29,202.08, ��36,035.13, and ��57,572.92, respectively. Figures 3 and ?and44 illustrate that within the mild/moderate and major SOI strata, LOS and cost increase significantly (P mortality is similar to other recently published series, including a recent study from the Society of Thoracic Surgeons (STS) database reporting an inpatient mortality of 2.6% for AVR in 2006.5 In a similar analysis of the NIS, Astor et al7 reported a 4.5% mortality for patients undergoing AVR in 1994, thus providing additional data to suggest that outcomes in patients undergoing surgical AVR are improving measurably over [http://www.selleckchem.com/products/cx-5461.html Selleck CX5461] time. Mild, moderate, and major severity of comorbid illness This analysis provides further evidence that isolated surgical AVR provides excellent outcomes in well-selected patients regardless of age.5,6,8 Among patients in the mild/moderate and major SOI strata (which includes 85% of the total study population), in-hospital mortality for the entire study population was 0.35% and 1.51%, respectively. Though in-hospital mortality was threefold to fourfold higher in the ��80-year-old group compared with those aged [http://www.selleckchem.com/products/forskolin.html Forskolin chemical structure] than 2% among mild/moderate/major SOI across all age strata. Furthermore, more than 50% of ��80-year-old patients were discharged home (Figure 2). Finally, though total inpatient costs increased significantly with increasing age, the absolute differences were relatively small (Figure 4). Notably, median total in-hospital costs in the mild/moderate stratum are less than the cost of a transcatheter aortic valve device alone. These findings suggest that surgical AVR should remain the gold standard for treatment across a large proportion of patients with isolated AS.&lt;/div&gt;</summary>
		<author><name>Sextown39</name></author>	</entry>

	</feed>